FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
Food Safety News3d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Scientific American35m
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical Science
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
GLP-1 drugs could help prevent 34,000 heart attacks and strokes in the US each year, research suggests
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
FDA expands approval for drug to treat early-stage breast cancer
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Study: Strokes kill 7 million worldwide each year, and rates are rising
Climate change and worsening diets are sending global rates of stroke and stroke deaths skyward, a new study warns.
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Cantaloupe recall hits food retailers in 5 states as FDA warns of potential Salmonella: Symptoms and what to know
More than 200 cases of Kandy cantaloupe sold at retailers in five states have been recalled after the FDA warned of potential ...
Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the FDA ...